Crosstalk between IGF-1R and other Tumor Promoting Pathways

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|17|2912-2921

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2912-2921

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 7, 2007-03 ,pp. : 705-717

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting IGF-1 signaling pathways in gynecologic malignancies

By Bruchim Ilan   Werner Haim  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 307-320

Informa Healthcare

Access to resources Recommend Favorite

Cross-Talk between Tumor Cells and the Microenvironment at the Metastatic Niche

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1900-1908

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer

By Buck Elizabeth   Mulvihill Mark  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 605-621

Informa Healthcare

Access to resources Recommend Favorite

The correlation between miR‐146a C/G polymorphism and UHRF1 gene expression level in gastric tumor

By  

Journal of Digestive Diseases, Vol. 17, Iss. 3, 2016-03 ,pp. : 169-174

John Wiley & Sons Inc

Access to resources Recommend Favorite